California Supreme Court
May 8, 2015
Pharmaceutical company's agreement could violate Cartwright Act
The California Supreme Court ruled Thursday that Barr Laboratories Inc. may have violated the state's antitrust law when it accepted $400 million from Bayer Corp. to delay the sale of its generic version of a popular antibiotic.
Daily Journal Staff Writer
After a series of victories in the trial and appellate courts, Barr Laboratories Inc.'s
winning streak came to an end when the California Supreme Court ruled Thursday that
it may have violated the state's antitrust law when it accepted $400 million from
Bayer Corp. to delay the sale of its generic version of a popular antibiotic.
...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In